Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002). (1st November 2002)

• Record Type: Journal Article
• Authors: Furst, D E; Breedveld, F C; Kalden, J R; Smolen, J S; Antoni, C E; Bijlsma, J W J; Burmester, G R; Cronstein, B; Keystone, E C; Kavanaugh, A; Klareskog, L
• Is Part Of: Annals of the rheumatic diseases. Volume 61(2002)Supplement 2
• Page Start: ii2
• Page End: ii7
• Publication Date: 2002-11-01
• Subjects: tumour necrosis factor α -- blocking agents -- rheumatoid arthritis -- biological agents; aCL, anticardiolipin antibody -- ACR, American College of Rheumatology -- ANA, antinuclear antibody -- DAS, disease activity score -- DMARD, disease modifying antirheumatic drug -- HAQ-DI, Health Assessment Questionnaire disease index -- IL, interleukin -- MTX, methotrexate -- RA, rheumatoid arthritis -- TNF, tumour necrosis factor -- VAS, visual analogue scale; Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/ard.61.suppl_2.ii2
• Languages: English
• ISSNs: 0003-4967